Asia Pacific Connected Drug Delivery Devices Market Size & Outlook

The connected drug delivery devices market in Asia Pacific is expected to reach a projected revenue of US$ 5,513.2 million by 2030. A compound annual growth rate of 24.1% is expected of Asia Pacific connected drug delivery devices market from 2023 to 2030.

Revenue, 2022 (US$M)
$982.1
Forecast, 2030 (US$M)
$5,513.2
CAGR, 2023 - 2030
24.1%
Report Coverage
Asia Pacific

Asia Pacific connected drug delivery devices market highlights

  • The Asia Pacific connected drug delivery devices market generated a revenue of USD 982.1 million in 2022.
  • The market is expected to grow at a CAGR of 24.1% from 2023 to 2030.
  • In terms of segment, parenteral was the largest revenue generating route of administration in 2022.
  • Inhalational is the most lucrative route of administration segment registering the fastest growth during the forecast period.
  • Country-wise, India is expected to register the highest CAGR from 2023 to 2030.

Asia Pacific data book summary

Market revenue in 2022USD 982.1 million
Market revenue in 2030USD 5,513.2 million
Growth rate24.1% (CAGR from 2022 to 2030)
Largest segmentParenteral
Fastest growing segmentInhalational
Historical data covered2018 - 2021
Base year for estimation2022
Forecast period covered2023 - 2030
Quantitative unitsRevenue in USD million
Market segmentationInhalational, Parenteral
Key market players worldwideTeva Pharmaceutical Industries Ltd, Novo Nordisk A/S ADR, Medtronic PLC, Adherium Ltd, Tandem Diabetes Care Inc, Propeller Health, Ypsomed Holding AG, AptarGroup Inc

Other key industry trends

  • In terms of revenue, Asia Pacific region accounted for 20.3% of the global connected drug delivery devices market in 2022.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • MEA is the fastest growing regional market and is projected to reach USD 971.4 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Connected Drug Delivery Devices Market Companies

Name Profile # Employees HQ Website

Asia Pacific connected drug delivery devices market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to connected drug delivery devices market will help companies and investors design strategic landscapes.


Parenteral was the largest segment with a revenue share of 56.19% in 2022. Horizon Databook has segmented the Asia Pacific connected drug delivery devices market based on inhalational, parenteral covering the revenue growth of each sub-segment from 2018 to 2030.


  • Asia Pacific Connected Drug Delivery Devices Route of Administration Outlook (Revenue, USD Million, 2018-2030)
    • Inhalational
    • Parenteral
  • Asia Pacific Connected Drug Delivery Devices Product Outlook (Revenue, USD Million, 2018-2030)
    • Standalone Components & Software
    • Integrated Devices
  • Asia Pacific Connected Drug Delivery Devices Application Outlook (Revenue, USD Million, 2018-2030)
    • Asthma
    • COPD
    • Diabetes Management
    • Other Applications

Reasons to subscribe to Asia Pacific connected drug delivery devices market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Asia Pacific connected drug delivery devices market databook

  • Our clientele includes a mix of connected drug delivery devices market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific connected drug delivery devices market, including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific connected drug delivery devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Asia Pacific connected drug delivery devices market size, by country, 2018-2030 (US$M)

Asia Pacific Connected Drug Delivery Devices Market Share, 2022 & 2030 (US$M)

Asia Pacific connected drug delivery devices market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more